Manasherob, Robert
Warren, Shay I.
Flanagan, Christopher M.
Arora, Prerna
Heo, Lyong
Moore, Christopher J.
Chow, Simon K. H.
Otieno-Ayayo, Z. Ngalo
Furukawa, Daisuke
Maloney, William J.
Lowenberg, David W.
Goodman, Stuart B.
Amanatullah, Derek F. https://orcid.org/0000-0002-6203-5853
Funding for this research was provided by:
Translational Research and Applied Medicine, School of Medicine, Stanford University (Translational Research and Applied Medicine, School of Medicine, Stanford University)
Orthopedic Research and Education Foundation (Jorge O. Galante Total Joint Replacement Award)
Osteosynthesis and Trauma Care Foundation (Osteosynthesis and Trauma Care Foundation)
National Center for Advancing Translational Sciences (KL2TR003143)
Article History
Received: 18 September 2025
Accepted: 29 October 2025
First Online: 12 December 2025
Declarations
:
: This observational study was conducted after institutional review board approval at Stanford University (Biosaftey #4328, Clinical Safety #54462 and #72855).
: Each of the listed authors has read and consents to the publication of this work in the Journal of Translational Medicine .
: The authors declare that they have no personal or professional competing interests. The Stanford Office of Technology and Licensing has submitted intellectual property regarding the diagnosis of implant-associated dormant infections based on these proteomic and functional findings (Docket #24–143 and Docket #24–240, US Patent Pending #63/677,070, PCT-US25/039107).